⌘K

Home/Filings/4/0001209191-15-087387

4//SEC Filing

ACHILLION PHARMACEUTICALS INC 4

Accession 0001209191-15-087387

CIK 0001070336operating

View on SEC.gov Company Profile

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 4:26 PM ET

Size

8.7 KB

Accession

0001209191-15-087387

Insider Transaction Report

Form 4

Period: 2015-12-30

ACHILLION PHARMACEUTICALS INCACHN

EVP and Chief Medical Officer

Transactions

Sale
Common Stock
2015-12-30$10.50/sh−10,000$105,000→ 0 total
Exercise/Conversion
Common Stock
2015-12-30$3.02/sh+10,000$30,200→ 10,000 total
Exercise/Conversion
Employee Stock Option
2015-12-30−10,000→ 290,000 total
Exercise: $3.02Exp: 2023-12-17→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]This option was granted on December 17, 2013 and vests over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three month-month period thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ACHILLION PHARMACEUTICALS INC

CIK 0001070336

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001070336

Filing Metadata

Form type: 4
Filed: Dec 29, 7:00 PM ET
Accepted: Dec 30, 4:26 PM ET
Size: 8.7 KB

View on SEC.gov